Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrodysplasia Ossificans Progressiva (FOP)”

Showing 4 of 0 results

Not applicableLooking for participantsNCT06089616
What this trial is testing

Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ipsen 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05394116
What this trial is testing

Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals 63
Large-scale testing (Phase 3)Study completedNCT03312634
What this trial is testing

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 107
Early research (Phase 1)Study completedNCT04818398
What this trial is testing

Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Daiichi Sankyo Co., Ltd. 48

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation